Related Experiment Video

Updated: Jun 1, 2026

Novel In Vivo Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease
08:41

Novel In Vivo Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease

Published on: March 24, 2023

microRNAs: fad or future of liver disease

Ashley M Lakner1, Herbert L Bonkovsky, Laura W Schrum

  • 1Department of Biology, University of North Carolina at Charlotte, Charlotte, 28223 NC, United States.

World Journal of Gastroenterology
|June 3, 2011
PubMed

Insights

MicroRNAs (miRs) are key regulators of gene expression impacting liver development and disease. This review explores their role in chronic liver conditions and therapeutic potential.

Area of Science:

  • Molecular Biology
  • Genetics
  • Hepatology

Background:

  • MicroRNAs (miRs) are small non-coding RNAs regulating gene expression.
  • They influence mRNA stability and translation, affecting cellular processes.
  • miRs are crucial in liver development and disease pathogenesis.

Purpose of the Study:

  • To review the role of miRs in liver development.
  • To explore miRs' involvement in chronic liver diseases like NAFLD and fibrosis.
  • To highlight miRs as potential therapeutic targets in liver disease.

Main Methods:

  • Literature review of recent studies on miRs in liver biology and disease.
  • Focus on miRs' impact on hepatic stellate cells.
  • Analysis of miRs as therapeutic tools.

Main Results:

  • miRs are critical regulators of liver development and function.
  • Dysregulation of miRs is implicated in non-alcoholic fatty liver disease, fibrosis, and cirrhosis.
  • Hepatic stellate cells are significantly influenced by miRs.

Conclusions:

  • miRs play a vital role in the pathogenesis of chronic liver diseases.
  • miRs represent promising biomarkers and therapeutic targets for liver conditions.
  • Further research into miRs could lead to novel treatment strategies.
Keywords:
FibrosisHepatic stellate cellsLivermRNAmicroRNA

More Related Videos

In Vivo Nanovector Delivery of a Heart-specific MicroRNA-sponge09:53

In Vivo Nanovector Delivery of a Heart-specific MicroRNA-sponge

Published on: June 15, 2018

Quantitative Real-Time Polymerase Chain Reaction Evaluation of MicroRNA Expression in Kidney and Serum of Mice with Age-Dependent Renal Impairment06:48

Quantitative Real-Time Polymerase Chain Reaction Evaluation of MicroRNA Expression in Kidney and Serum of Mice with Age-Dependent Renal Impairment

Published on: April 29, 2022

Related Concept Videos

Ultrasound II: Endoscopic Ultrasound and FibroScan01:25

Ultrasound II: Endoscopic Ultrasound and FibroScan

Endoscopic Ultrasound (EUS) and FibroScan are valuable diagnostic tools in gastroenterology and hepatology, each with specific applications and techniques.
Endoscopic Ultrasound (EUS):
Cirrhosis I: Introduction01:23

Cirrhosis I: Introduction

Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...